Support WBURFDA Fees On Industry Haven't Fixed Delays In Generic Drug ApprovalsSydney LupkinSeptember 01, 2016 ShareWhere are the generic alternatives to EpiPen and other expensive drugs that have lost patent protection? (Bloomberg via Getty Images)